RxDoctor Payments Data

Razvan Pavelescu, DPM

Foot & Ankle Surgery · New York, NYNPI 1699032672

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Stability Biologics, LLC at 50.9% of the total. 2025 is the largest year on record at $12,880, more than ten times the $998 reported in 2019. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,822in general payments, 2019–2025

Across 93 payments — averaging $213.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stability Biologics, LLC$10K
  • Smith+Nephew$5K
  • Gotham Surgical Solutions & Devices, Inc.$3K
  • Stryker$474
  • Kerecis Limited$354
  • AbbVie$289
  • plus $1K from 18 others

What the payments were for

  • Consulting fees$10,59753%
  • Speaking & faculty fees$160%
  • Travel & lodging$2,98915%
  • Food & beverage$3,82019%
  • Education$2,40012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stability Biologics, LLC2$10,097
Smith+Nephew40$4,593
Gotham Surgical Solutions & Devices, Inc.4$2,927
Stryker(2 entities)8$474
Kerecis Limited6$354
AbbVie(2 entities)3$289
Organogenesis Inc.6$211
Amgen(2 entities)2$165
Treace Medical Concepts, Inc.2$157
Next Science LLC1$125
Orthofix Medical, Inc.2$68
DJO, LLC2$55
Paratek Pharmaceuticals, Inc.3$54
Solventum Corporation1$45
Coastal Medical Technologies LLC2$36
Convatec Inc.1$31
Mimedx Group, Inc.1$24
Novum Pharma, LLC1$20
Bioventus LLC1$19
Reprise Biomedical, Inc.1$18
Medline Industries LP1$17
Johnson & Johnson1$16
Cashflow Solutions, LLC1$16
Zyla Life Sciences, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,822 in reported general payments places this provider in the 90th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$1,710,619
Medicare patients
371
Services billed
4,775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl295$1,759
Ciprofloxacin Hcl87$1,297
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav59$839
Ciclopirox16$615
Ammonium Lactate26$597
Ketoconazole23$531
Minocycline Hcl35$510
Meloxicam150$360
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$217
Doxycycline Hyclate17$182
SsdSilver Sulfadiazine15$108
Silver Sulfadiazine32$105
Mupirocin12$95
Gabapentin11$93

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →